Persistent occult hepatitis B virus infection: experimental findings and clinical implications.
about
Genetic variation of occult hepatitis B virus infectionOccult hepatitis B virus infectionPrimary seronegative but molecularly evident hepadnaviral infection engages liver and induces hepatocarcinoma in the woodchuck model of hepatitis BOccult infection with hepatitis C virus: friend or foe?Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipientsOccult hepatitis B virus and hepatocellular carcinomaMolecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.Occult hepatitis B virus and hepatitis C virus infections.Diagnostic strategy for occult hepatitis B virus infection.Occult HBV Infection in Immunized Neonates Born to HBsAg-Positive Mothers: A Prospective and Follow-Up Study.Occult HBV infection.Repeated exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and hepatitisHepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor.Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.Primary occult hepadnavirus infection induces virus-specific T-cell and aberrant cytokine responses in the absence of antiviral antibody reactivity in the Woodchuck model of hepatitis B virus infectionPrevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA.Molecular characteristics and stages of chronic hepatitis B virus infectionOccult hepatitis B: clinical implications and treatment decisions.Pathogenesis of occult chronic hepatitis B virus infectionClinical significance of occult hepatitis B infection in progression of liver disease and carcinogenesis.Designing primers from multiple sequences using Matchup program to improve detection of hepatitis B virus by polymerase chain reaction.Molecular mechanisms underlying HBsAg negativity in occult HBV infection.Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients.Occult hepatitis B virus infection: clinical implications in tuberculosis treatment.Aberrant lymphocyte activation precedes delayed virus-specific T-cell response after both primary infection and secondary exposure to hepadnavirus in the woodchuck model of hepatitis B virus infection.Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis BHepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial.The clinical significance of occult HBV infection.Occult hepatitis B: clinical viewpoint and management.The woodchuck hepatitis B virus infection model for the evaluation of HBV therapies and vaccine therapies.Occult hepatitis B virus infection in Thai blood donors.Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin.A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection
P2860
Q26751031-78986B5A-F95A-4E3F-8360-D0436CF86658Q27004224-95EF3585-129C-4AE7-863A-B889B55DCCCBQ28542638-1D688C6C-A042-4997-8F32-6E6616CD42FCQ30416187-DC27915A-BD59-4D51-B5B2-DC40339101A1Q30431051-D0B8387F-A436-45A5-AD5F-70537EC24998Q33661018-7B31B767-3F3D-4C80-B008-4ED1629B3943Q34080966-BC5F8F58-2C76-4D61-842F-E2D8E68FBC33Q34748898-042D118F-17B5-4754-9C3F-73E3E970D12BQ34757381-C3ACCDBE-5F4E-4044-915B-BBB331FA92E2Q36190007-EBDE33B0-BAE8-418C-A6F8-ECCB1BF2F0CAQ36518847-3E2B5252-462C-4A98-AE3C-D1133C18A1F3Q36559497-57747095-96C0-4F9E-B254-04595E06473AQ36623471-92DD9449-579D-4081-A605-733EADD4E0B9Q36876536-5543A2D9-804C-4C86-B4B7-ECCF8FB9322AQ37145259-F1BB2C51-4E49-4E0C-9293-4A840E0CA007Q37232154-0CF78B70-CB25-4843-8012-F0AD90C4E6BAQ37250341-9250B26D-799D-42FC-9F32-A77B8CDD5BDAQ37798473-498A160E-B37B-4883-AD8B-FCC249696D7CQ37862591-AEE68BDF-D951-48CB-876B-3724BDAAFEA2Q38125450-104267B7-51AA-4A73-80CA-72B24FE67A4DQ38345854-B0AAEF8B-B580-44D7-80D1-D7309987664FQ38536404-4D7B6713-8732-4E58-97DF-30F30A8C0CA1Q38989985-232D575C-D735-449F-8269-58CC991EBBE1Q39394078-8C3EEE17-25C1-4E80-8C17-15195601B170Q39764120-C0F1418A-00C1-4226-8F87-C74D5A3484D3Q39903499-E67F0ED0-7F53-4BE6-AF14-3582749FC8A8Q42004056-5923E61B-430A-46DD-A7CD-20EEAF03C1B4Q42242620-2718A2EB-8C61-4CA6-9BBC-33B042D074CDQ42406515-79607CDD-DE16-4CE8-AA2C-ED6ED8D66EDCQ43223881-FDDEE105-BDB4-4167-ADD1-E0D29479E5C1Q45356038-87BCC654-22C1-4E52-AEAC-B53E524A7608Q45369715-8C947ACA-7185-447F-9982-3C258C9A2D94Q50560155-A0191424-C116-446C-BC02-86AEEFE93F46Q56979536-6CDA8918-FC00-455F-B331-65BA47B527FF
P2860
Persistent occult hepatitis B virus infection: experimental findings and clinical implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Persistent occult hepatitis B ...... ngs and clinical implications.
@en
Persistent occult hepatitis B ...... ngs and clinical implications.
@nl
type
label
Persistent occult hepatitis B ...... ngs and clinical implications.
@en
Persistent occult hepatitis B ...... ngs and clinical implications.
@nl
prefLabel
Persistent occult hepatitis B ...... ngs and clinical implications.
@en
Persistent occult hepatitis B ...... ngs and clinical implications.
@nl
P2860
P356
P1476
Persistent occult hepatitis B ...... ngs and clinical implications.
@en
P2093
Patricia M Mulrooney-Cousins
Tomasz I Michalak
P2860
P304
P356
10.3748/WJG.V13.I43.5682
P407
P577
2007-11-01T00:00:00Z